Millennium Management
MIST icon

Millennium Management’s Milestone Pharmaceuticals MIST Stock Holding History

Millennium Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-24,600
Closed -$226K – 6851
2022
Q3 		$226K Buy
+24,600
New +$187K ﹤0.01% 5571

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Millennium Management's MIST Position: Q1 2026 in Review

Millennium Management increased its Milestone Pharmaceuticals (MIST) stake by 284% in Q1 2026, buying an estimated $2M and bringing the position to 1,544,325 shares worth $1.84M. The position accounts for ﹤0.01% of the portfolio, ranked #3948.

Millennium Management first reported a position in MIST in Q2 2019 and has held it in 26 quarters since. The position peaked at $8.57M in Q3 2022. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Millennium Management held 1,544,325 shares of Milestone Pharmaceuticals worth $1.84M as of Q1 2026.
  • Millennium Management bought 1,141,690 Milestone Pharmaceuticals shares in Q1 2026, an estimated $2M.
  • Milestone Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3948 holding.
  • Millennium Management first reported a position in Milestone Pharmaceuticals in Q2 2019 and has held it in 26 quarters since.
  • Millennium Management's Milestone Pharmaceuticals position peaked at $8.57M in Q3 2022.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.